SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-043719
Filing Date
2020-07-27
Accepted
2020-07-27 13:59:39
Documents
1
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5697
  Complete submission text file 0001209191-20-043719.txt   7145
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10445 PACIFIC CENTER CT SAN DIEGO CA 92121
Business Address
GOLD DANIEL P PHD (Reporting) CIK: 0001288233 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 201050049